logo
iBio

iBio

iBio, Inc. (IBIO:AMEX), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBioLaunch™ platform. The iBioLaunch platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines. It uses proprietary, transient gene expression in unmodified green plants instead of materials such as chicken eggs, mammalian and insect cells, transgenic plants, and human blood plasma required by other systems, to produce important biologic pharmaceuticals.

EPIC: IBIO
Market: AMEX
52-week High/Low: $1.09 / $0.54
Sector: Pharmaceuticals
Market Cap: $16.16M
Website: www.ibioinc.com

Popular Content

Tag Content